2197TPhosphoChk2 Thr68 C13C1 Rabbit Monoclon and 3 more items

Cell Signaling Technology has been awarded a contract by Virginia Commonwealth University (VCU) effective August 3, 2026, with a cumulative contract value of $698. The contract is being executed in the Commonwealth of Virginia and calls for the delivery of four distinct research reagents to VCU Procurement. The line items consist of specialized antibody products including PhosphoChk2 Thr68 C13C1 Rabbit Monoclonal Antibody ($143.65), PhosphoHistone H2AX Ser139 Antibody ($315.35), FADD Antibody ($114.75), and Caspase8 1C12 Mouse Monoclonal Antibody ($124.95).

These antibody reagents appear to support molecular biology and cellular research applications at VCU, with each item procured in a quantity of one unit. The contract represents a materials procurement for laboratory research purposes, with all deliverables designated for receipt at VCU Procurement. The relatively modest contract value and single-unit quantities suggest this procurement supports specific research requirements at the institution rather than representing an ongoing or recurring supply arrangement.